Annexin A1 attenuates EMT and metastatic potential in breast cancer

Por Maschler, Sabine, Gebeshuber, Christoph A, Wiedemann, Eva-Maria, Alacakaptan, Memetcan, Schreiber, Martin, Custic, Ivana, Beug, Hartmut
Publicado em 2010

Diverging fates of cells of origin in acute and chronic leukaemia

Por Kovacic, Boris, Hoelbl, Andrea, Litos, Gabriele, Alacakaptan, Memetcan, Schuster, Christian, Fischhuber, Katrin M, Kerenyi, Marc A, Stengl, Gabriele, Moriggl, Richard, Sexl, Veronika, Beug, Hartmut
Publicado em 2012

Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen–urokinase plasminogen activator receptor system–regul...

Por Csiszar, Agnes, Kutay, Betül, Wirth, Silvia, Schmidt, Ulrike, Macho-Maschler, Sabine, Schreiber, Martin, Alacakaptan, Memetcan, Vogel, Georg F, Aumayr, Karin, Huber, Lukas A, Beug, Hartmut
Publicado no Breast Cancer Res (2014)

BI 5700, a Selective Chemical Inhibitor of IκB Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression

Por Huber, Margit A., Maier, Harald J., Alacakaptan, Memetcan, Wiedemann, Eva, Braunger, Jürgen, Boehmelt, Guido, Madwed, Jeffrey B., Young, Erick R.R., Marshall, Daniel R., Pehamberger, Hubert, Wirth, Thomas, Kraut, Norbert, Beug, Hartmut
Publicado em 2010